BSECompany UpdateExpansion21 Aug 2026
Astonea Labs Ltd
Approval of Alteration in Object Clause of the Memorandum of Association ("MOA") of the Company
Astonea Labs Ltd has approved an alteration in its Memorandum of Association to expand and align its objects with its existing and proposed business activities in the pharmaceutical, nutraceutical, healthcare, ayurvedic, and allied sectors.
BSECompany UpdateMgmt Change21 Aug 2026
Astonea Labs Ltd
Re-appointment of Ms. Pooja Singh as Director of the Company
Astonea Labs Ltd re-appoints Ms. Pooja Singh as Director, effective August 21, 2026, following her retirement by rotation. Ms. Singh has over eight years of experience in the pharmaceutical industry, with expertise in Quality Assurance and Drug Regulatory Affairs.
BSEAGM/EGM21 Aug 2026
Astonea Labs Ltd
Scrutinizer''s Reports and Voting Results of the 9th Annual General Meeting ("AGM") of the Company held on 21st August, 2026
Astonea Labs Ltd has submitted the voting results and scrutinizer's report for its 9th Annual General Meeting (AGM) held on August 21, 2026, where all resolutions were approved by the members with the requisite majority.
BSEAGM/EGMResults21 Aug 2026
Astonea Labs Ltd
Proceedings of 9th Annual General Meeting ("AGM") of the Company for the financial year 2025-26 held on 21st August, 2026
Astonea Labs Ltd held its 9th Annual General Meeting (AGM) on August 21, 2026, where six members were present. The meeting was convened to discuss the company's financial performance for FY 2025-26, which showed revenue of approximately Rs. 148 Crore and Profit After Tax (PAT) of approximately Rs. 4.51 Crore. The meeting also discussed the adoption of the Audited Standalone and Consolidated Financial Statements, the re-appointment of Ms. Pooja Singh as a director, and the ratification of the remuneration of the Cost Auditor.
BSECompany Update25 Jul 2026
Astonea Labs Ltd
Intimation regarding Newspaper Publication of Notice of 9th Annual General Meeting ("AGM") of the Company.
Astonea Labs Ltd has published a notice of its 9th Annual General Meeting (AGM) in newspapers and on its website, as required by SEBI regulations.
BSEOthersResults24 Jul 2026
Astonea Labs Ltd
Annual Report of the Company for the Financial year 2025-26.
Astonea Labs Ltd has submitted its Annual Report for the Financial Year 2025-26, as per Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report includes the Notice convening the 9th Annual General Meeting, Board's Report, Audited Financial Statements, and Statutory Auditors' Report.
BSEAGM/EGMResults24 Jul 2026
Astonea Labs Ltd
Please find enclosed herewith an attached Notice of 9th Annual General Meeting ("AGM") of the Company for the Financial Year 2025-26 scheduled to be held on Friday, 21st August, 2026.
Astonea Labs Ltd has announced the notice of its 9th Annual General Meeting (AGM) scheduled to be held on August 21, 2026, at Mercure Hotel, Chandigarh. The meeting will consider and transact various businesses, including the adoption of audited standalone financial statements for the financial year ended March 31, 2026.
BSECompany Update24 Jul 2026
Astonea Labs Ltd
Intimation under Regulation 30- Revision in Re-appointment of Tax Auditor under Income Tax Act, 2025
Astonea Labs Ltd has revised its tax auditor appointment under the Income-tax Act, 2025, with M/s. Avnish Sharma & Associates continuing as the tax auditor for the tax year 2026-27.
BSEResultResults24 Jul 2026
Astonea Labs Ltd
Audited Consolidated Financial Results for the Half year and year ended 31.03.2026
Astonea Labs Ltd has announced its audited consolidated financial results for the half year and year ended 31.03.2026, with the board of directors approving the results and authorizing the submission to the stock exchange. The results include an unmodified opinion from the statutory auditors.
BSEBoard MeetingResults24 Jul 2026
Astonea Labs Ltd
Outcome of the Board Meeting held on 24th July, 2026
Astonea Labs Ltd has announced the outcome of its Board Meeting held on 24th July, 2026, where it approved the audited consolidated financial results for the half year and financial year ended 31st March, 2026, along with the audited standalone financial results for the financial year ended 31st March, 2026. The Board also approved the declaration of the audited consolidated financial results, and the trading window for dealing in the securities of the Company has been reopened. Additionally, the Board approved the draft Board's Report for the financial year 2025-26 and the Annual Report for the financial year ended 31st March, 2026.